1 |
Aknemin |
- |
- |
- |
- |
201 [1] 201 💬 |
2 |
Aknemin 50 |
- |
- |
- |
- |
201 [1] 201 💬 |
3 |
Betaine |
Glycine betaine |
[1] D07523 D07523 💬 |
- |
- |
201 [1] 201 💬 |
4 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
5 |
Creatine |
Creatine |
- |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
6 |
Gaboxadol |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [2] 201, 206 💬 |
7 |
Gaboxadol monohydrate |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
8 |
Gaboxadol monohydrate 0.5 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
9 |
Gaboxadol monohydrate 0.5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
10 |
Gaboxadol monohydrate 0.5 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
11 |
Gaboxadol monohydrate 2 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
12 |
Gaboxadol monohydrate 2 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
13 |
Gaboxadol monohydrate 2 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
14 |
Gaboxadol monohydrate 5 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
15 |
Gaboxadol monohydrate 5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
16 |
Gtx-102 |
- |
- |
- |
- |
201 [1] 201 💬 |
17 |
Levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
18 |
Levodopa/carbidopa (4:1) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
201 [1] 201 💬 |
19 |
Metafolin |
- |
- |
- |
- |
201 [1] 201 💬 |
20 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
21 |
Minocycline hydrochloride |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
013 [4] 13, 201, 206, 299 💬 |
22 |
Nutritional formulation containing exogenous ketones |
- |
- |
- |
- |
201 [1] 201 💬 |
23 |
Ov101 |
- |
- |
- |
- |
201 [2] 201, 206 💬 |
24 |
Ov101 regimen 1 |
- |
- |
- |
- |
201 [1] 201 💬 |
25 |
Ov101 regimen 2 |
- |
- |
- |
- |
201 [1] 201 💬 |
26 |
Ro7248824 |
- |
- |
- |
- |
201 [1] 201 💬 |
27 |
Ro7248824/f02-01 |
- |
- |
- |
- |
201 [1] 201 💬 |
28 |
Ro7248824/f03-01 (diluent for ro7248824/f02-01 |
- |
- |
- |
- |
201 [1] 201 💬 |
29 |
Vitamin b12 |
Cyanocobalamin |
[4] D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
006 [4] 6 , 201, 229, 299 💬 |